Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 10 07 2020
accepted: 28 04 2021
pubmed: 5 5 2021
medline: 15 2 2022
entrez: 4 5 2021
Statut: epublish

Résumé

The chemokine system of ligands and receptors is implicated in the progression of alcohol-associated hepatitis (AH). Finding upstream regulators could lead to novel therapies. This study involved coordinated expression of chemokines in livers of healthy controls (HC) and patients with AH in 2 distinct cohorts of patients with various chronic liver diseases. Studies in cultured hepatocytes and in tissue-specific KO were used for mechanistic insight into a potential upstream regulator of chemokine expression in AH. Selected C-X-C chemokine members of the IL-8 chemokine family and C-C chemokine CCL20 were highly associated with AH compared with HC but not in patients with liver diseases of other etiologies (nonalcoholic fatty liver disease [NAFLD] and hepatitis C virus [HCV]). Our previous studies implicate macrophage migration inhibitory factor (MIF) as a pleiotropic cytokine/chemokine with the potential to coordinately regulate chemokine expression in AH. LPS-stimulated expression of multiple chemokines in cultured hepatocytes was dependent on MIF. Gao-binge ethanol feeding to mice induced a similar coordinated chemokine expression in livers of WT mice; this was prevented in hepatocyte-specific Mif-KO (MifΔHep) mice. This study demonstrates that patients with AH exhibit a specific, coordinately expressed chemokine signature and that hepatocyte-derived MIF might drive this inflammatory response.

Identifiants

pubmed: 33945507
pii: 141420
doi: 10.1172/jci.insight.141420
pmc: PMC8262327
doi:
pii:

Substances chimiques

Chemokine CCL20 0
Chemokines 0
Lipopolysaccharides 0
Macrophage Migration-Inhibitory Factors 0
Intramolecular Oxidoreductases EC 5.3.-
MIF protein, human EC 5.3.2.1
Mif protein, mouse EC 5.3.2.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAAA NIH HHS
ID : U01 AA026938
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA023722
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA026648
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR049610
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021890
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA026648
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA024333
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020821
Pays : United States

Références

Handb Exp Pharmacol. 2018;248:347-367
pubmed: 29374837
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S
pubmed: 10803780
Aliment Pharmacol Ther. 2014 Aug;40(3):261-79
pubmed: 24890045
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7917-E7926
pubmed: 27872288
Hepatology. 2017 Aug;66(2):555-563
pubmed: 28120471
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9354-9
pubmed: 12878730
Hepatol Commun. 2020 Aug 04;4(10):1459-1476
pubmed: 33024916
PLoS One. 2011;6(6):e21381
pubmed: 21731723
Gut. 2013 Mar;62(3):452-60
pubmed: 22637703
Immunogenetics. 2002 Nov;54(8):599-603
pubmed: 12439624
Front Immunol. 2020 Apr 17;11:322
pubmed: 32362892
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
J Hepatol. 1996 Apr;24(4):377-84
pubmed: 8738722
J Immunol. 2006 Dec 1;177(11):8072-9
pubmed: 17114481
Gut. 2014 Nov;63(11):1782-92
pubmed: 24415562
J Hepatol. 2019 Feb;70(2):249-259
pubmed: 30658726
J Leukoc Biol. 1998 Oct;64(4):494-502
pubmed: 9766630
Alcohol Clin Exp Res. 2019 Jul;43(7):1439-1451
pubmed: 31009094
Thromb Haemost. 2013 Mar;109(3):391-8
pubmed: 23329140
Gastroenterology. 2014 Sep;147(3):577-594.e1
pubmed: 25066692
Gastroenterology. 2014 May;146(5):1231-9.e1-6
pubmed: 24440674
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17444-9
pubmed: 21969590
Hepatology. 2013 May;57(5):1980-91
pubmed: 23174952
Hepatology. 2015 Oct;62(4):1070-85
pubmed: 26033752
Nat Commun. 2019 Jul 16;10(1):3126
pubmed: 31311938
Sci Rep. 2016 Jun 08;6:27665
pubmed: 27273604
Front Genet. 2019 Jan 22;9:636
pubmed: 30723492
Hepatology. 2014 Feb;59(2):580-91
pubmed: 23913513
Free Radic Biol Med. 2013 Oct;63:236-42
pubmed: 23707455
BMC Genomics. 2005 Mar 24;6:45
pubmed: 15790398
Toxicol Mech Methods. 2007;17(7):431-40
pubmed: 20020946
Cell Mol Immunol. 2016 May;13(3):301-15
pubmed: 26685902
Hepatology. 2011 Dec;54(6):2185-97
pubmed: 21826694
Nat Protoc. 2013 Mar;8(3):627-37
pubmed: 23449255
Gastroenterology. 2009 May;136(5):1639-50
pubmed: 19208360
J Immunol. 2009 Jun 1;182(11):6896-906
pubmed: 19454686
FASEB J. 2014 Dec;28(12):5136-47
pubmed: 25122558
Cells. 2021 Jan 28;10(2):
pubmed: 33525493
Alcohol. 2002 May;27(1):23-7
pubmed: 12062633
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
J Hepatol. 2017 Nov;67(5):1018-1025
pubmed: 28647568
Cell Mol Immunol. 2014 Jan;11(1):25-40
pubmed: 23954947
Front Physiol. 2012 Jun 20;3:213
pubmed: 22723782
Gastroenterology. 1996 Jun;110(6):1847-53
pubmed: 8964410
Hepatology. 2013 Nov;58(5):1814-23
pubmed: 23532958

Auteurs

Kyle L Poulsen (KL)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.

Xiude Fan (X)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Christopher D Kibler (CD)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.

Emily Huang (E)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.

Xiaoqin Wu (X)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.

Megan R McMullen (MR)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.

Lin Leng (L)

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Richard Bucala (R)

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Meritxell Ventura-Cots (M)

Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh Liver Research Center, Pittsburgh, Pennsylvania, USA.

Josepmaria Argemi (J)

Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh Liver Research Center, Pittsburgh, Pennsylvania, USA.

Ramon Bataller (R)

Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh Liver Research Center, Pittsburgh, Pennsylvania, USA.

Laura E Nagy (LE)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.
Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH